The company reports total molecular diagnostic Q4 revenue of about $86 mln, which represents the bulk of the company's revenue. The Street view for total revenue is $92 mln, according to Thomson Reuters.
9:01 AM, Jul 1, 2009 --
U.S. PRE-MARKET INDICATORS
-Dow Industrial futures up 36 points.
-S&P 500 futures up 4 points
-Nasdaq 100 futures up 6 points.
-Nasdaq-100 Pre-Market Indicator up 3.24 at 1480.49
GLOBAL SENTIMENT
Nikkei down 0.2%
Hang Seng closed for holiday.
FTSE-100 up 0.6%
PRE-MARKET SECTOR WATCH
(+) Large cap tech: mostly higher
(+) Chip stocks: mostly higher
(-,+) Small cap stocks: mixed
(-,+) Drug stocks: mixed
(+) Software stocks: firmer
(+,-) Internet stocks: mixed
(-,+) Financial stocks: mixed
(+,-) Auto stocks: mixed
(-,+) Airline stocks: mixed
(+,-) Retail stocks: mixed
UPSIDE MOVERS
(+) C (+0.3%) sells trust unit.
(+) OSK (+29.3%) inks $1 bln military order.
(+) GIS (+2.2%) beats with earnings.
(+) AMAG (+5.2%) sees continued reaction to FDA marketing approval for Feraheme.
(+) CRXX (+23.7%) to merge with privately held Neuromed.
(+) AZN (+0.6%) edges up as Iressa gets EU marketing approval.
(+) BORL (+17.8%) gets raised offer to $1.50/share cash.
(+) PPHM (+6%) wins European patent for in-line labeling.
DOWNSIDE MOVERS
(-) MYGN (-20%) continues evening slide after revenue warning.
(-) FRPT (-29.3%) NAV (-7.1%) declining after losing order to Oshkosh (OSK).
(-) AIG (NA) shareholders approve 1-for-20 reverse stock split.
(-) CHKP (flat) downgraded to Neutral at JP Morgan.
(-) SKBI (-25%) announces offering.
(-) ZZ (-12.2%) sees continued selling after announcing swing to loss in Tuesday's extended hours.
(-) BEAT (-37.2%) guides for FY results below Street view.
(-) GSIG (-23%) is restating some revenue.
(-) SPPI (-6.5%) raises $21 mln through offering.
